Log in for full access to this activity, if you are registered.

Registration Options

Activity Dates: 05/01/2011 - 05/01/2014

This course is closed. Please look for other available products in CPNP University.

Target Audience

If you are a pharmacist, nurse practitioner or other healthcare professional involved in the comprehensive medication management of psychiatric and/or neurological patients, we invite you to participate in this online course.

Session Summary

Since the development and introduction of the long-acting antipsychotic medications in the 1960’s, clinical debates have occurred among health-care providers as to when these medications are appropriate to use.  The impact of poor medication adherence among patients with psychiatric disorders has a great impact on their clinical outcomes.  Long-acting injectable antipsychotics have been shown to reduce hospitalizations and to improve medication adherence.  The clinical pharmacologic properties, safety and tolerability profiles of these medications vary between agents.  This interactive session will provide the clinical health-care provider with practical knowledge of the long-acting antipsychotic medications including how to determine which medication is appropriate for a specific patient, and how to optimize pharmaceutical treatment, improve adherence and minimize drug-related problems.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (login first)
  • Complete the evaluation at the end of the activity. (login first)
  • Receive a passing grade (60%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)

This course is provided online at cpnp.org and consists of the speaker audio and slides. A PDF file of the slides is also provided and access is available to participants indefinitely although ACPE credit is available only through the course expiration date.

Participants in this course must complete an examination and achieve a score of 60% or greater. Successful completion of the course also requires the completion of a course evaluation. ACPE statements of credit can be retrieved by participants online at cpnp.org immediately upon successful completion of the course.

Faculty Information and Disclosures

Eric C. Kutscher, PharmD, BCPP

View biographical information and disclosures

Learning Objectives

  1. Describe the evidence and rationale for use of long-acting antipsychotics to prevent relapse in schizophrenia.
  2. Analyze the safety, pharmacokinetic and pharmaceutical properties of long-acting injectable antipsychotics to optimize outcomes in patients with schizophrenia.
  3. Formulate a care plan to address drug-related problems (e.g., titration schedules, polypharmacy, costs, etc.) associated with long-acting injectable antipsychotics.

Continuing Education Credit and Disclosures

Activity Dates: 05/01/2011 - 05/01/2014
ACPE Contact Hours: 1.0
ACPE Number: 0284-9999-11-004-H01-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This self-study course provides 1.0 contact hours (0.10 CEUs) of knowledge-based continuing education credit from CPNP approved programming. The ACPE universal program number assigned to this course is 0284-0999-11-004-H01-P (1.0 contact hours).

ACPE approved contact hours are accepted for ANCC Certification Renewal (see pages 5 and 6): At least 50% (37.5 hours) of your 75 continuing education hours must be formally approved continuing education hours. Formally approved continuing education hours meet one or more of the criteria listed below:

  1. Continuing nursing education (CNE) approved for nursing contact hours by an accredited provider or approver of nursing continuing education
  2. Continuing medical education (CME) approved for CME hours
  3. Sponsored by organizations, agencies, or educational institutions accredited or approved by the American Nurses Credentialing Center (ANCC) or the Accreditation Council for Continuing Medical Education (ACCME) or the Accreditation Council for Pharmacy Education (ACPE) or the Commission on Dietetic Registration

Grant Support

Supported by an educational grant from Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC and Lilly USA, LLC.

This programming was supported in part by grants from Bristol-Myers Squibb, Cyberonics, Merk and Sunovion.

Annual Meeting Grant Supporter

BCPP Recertification Grant Supporter


Supported by an educational grant from Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC.


This activity is supported by an educational grant from Lilly USA, LLC. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.